Molecular Partners AG logo

Molecular Partners AG

XSWX:MOLN (Switzerland)  
CHF 3.85 (-3.02%) Feb 23
At Loss
P/B:
0.64
Market Cap:
CHF 126.49M ($ 143.64M)
Enterprise V:
CHF -76.18M ($ -86.51M)
Volume:
10.89K
Avg Vol (2M):
17.11K
Also Trade In:
Volume:
10.89K
At Loss
Avg Vol (2M):
17.11K

Business Description

Description
Molecular Partners AG is a clinical stage biopharmaceutical company. The company focuses on the discovery, development and prospective commercialization of a new class of biopharmaceutical products. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Financials (Next Earnings Date:2024-03-08 Est.)

XSWX:MOLN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Molecular Partners AG Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 8.699
EPS (TTM) (CHF) -1.83
Beta 0.47
Volatility % 47.01
14-Day RSI 43.33
14-Day ATR (CHF) 0.17039
20-Day SMA (CHF) 4.014
12-1 Month Momentum % -32.22
52-Week Range (CHF) 3.04 - 6.3
Shares Outstanding (Mil) 32.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Molecular Partners AG Filings

Filing Date Document Date Form
No Filing Data

Molecular Partners AG Stock Events

Financials Calendars
Event Date Price(CHF)
No Event Data

Molecular Partners AG Frequently Asked Questions

What is Molecular Partners AG(XSWX:MOLN)'s stock price today?
The current price of XSWX:MOLN is CHF3.85. The 52 week high of XSWX:MOLN is CHF6.30 and 52 week low is CHF3.04.
When is next earnings date of Molecular Partners AG(XSWX:MOLN)?
The next earnings date of Molecular Partners AG(XSWX:MOLN) is 2024-03-08 Est..
Does Molecular Partners AG(XSWX:MOLN) pay dividends? If so, how much?
Molecular Partners AG(XSWX:MOLN) does not pay dividend.

Press Release

Subject Date
No Press Release